GlaxoSmithkline Pharmaceuticals (down 1.21% at Rs 3,154.50) and Sanofi (down 1.26% at Rs 3,310) edged lower.

Meanwhile, the S&P BSE Sensex was down 145.11 points or 0.54% at 26,623.38.

According to reports, the Competition Commission of India (CCI) imposed a fine on GlaxoSmithkline Pharmaceuticals and Sanofi India for collusive bidding in supply of a meningitis vaccine to government for Haj pilgrims. A fine of Rs 60.45 crore has been slapped on GlaxoSmithKline Pharma and Rs 3.04 crore on Sanofi, reports added.

GlaxoSmithkline Pharmaceuticals' net profit rose 6.5% to Rs 102.85 crore on 2.3% growth in net sales to Rs 613.47 crore in the quarter ended 31 March 2015 over the quarter ended 31 March 2014.

GlaxoSmithkline Pharmaceuticals is engaged in the business of manufacturing, distributing and trading in pharmaceuticals.

Sanofi India's net profit rose 24.8% to Rs 64.50 crore on 9.5% growth in net sales to Rs 459.80 crore in Q1 March 2015 over Q1 March 2014.

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs.